medigraphic.com

2016, Number 1

<< Back Next >>

Rev Mex Anest 2016; 39 (1)

Baclofen as an GABA agonist b and its administration to improve the performance of neuropatic pain in rats

De Rungs-Brown DR, Víctor-Baldin A, Robles-Chileno ME

Language: Spanish
References: 43
Page: 20-29
PDF size: 271.13 Kb.


ABSTRACT

Baclofen is a GABA-B agonist drug used to treat mainly spasticity but it has shown some possible analgesic properties. The baclofen induced antinociception by GABA agonists depressing the central nervous system by decreasing the release of glutamate and aspartate. Objectives: Determine the antinociception effect of Baclofen after it administration in a model of neuropathic pain in rats. Material and methods: Thirty male albino rats of Wistar strain, weighing between 150 and 250 grams were used. Rats were prepared for surgery and anesthetized with intraperitoneal chloral hydrate. Right sciatic nerve was isolated and injured by constriction. Baclofen was applied in different doses (1, 4, 6 mg/kg) intra-peritoneal according to the experimental groups. The rats were subjected to a battery of various pain tests. Each test was performed on both hind legs. Repetitive ANOVA test was used and the p ‹ 0.05 was significant. Results: Pain measurement with Von Frey filaments of the left leg was 1.13 (± 0.32) mm as a base line in all groups, compared with the right leg that was1.04 (± 0.36) mm as the same condition. Significant differences were obtained after baclofen application in all the groups. Altered gait percentages in each group was remarkable in group A, and was ameliorate in group B, C, and D (p ‹ 0.001) and normal in group E. Autotomy, edema and leg retraction was observed like complications main in group C (20%) and D (40%). Conclusions: Baclofen demonstrated as an excellent antinociception drug to treat neuropathic pain in rats, and was dose-dependent.


REFERENCES

  1. Adriaensen H. Response properties of thin myelinated (a-delta) fibers in human ski nerves. J Neurophysiol. 1983;49:111-122.

  2. Baños JE, Ruiz-Barría G. La evaluación del dolor experimental en el laboratorio: los modelos de dolor neuropático en animales. Rev Soc Esp Dolor. 2006;13:542-552.

  3. Bessou P. Response of cutaneous sensory units with unmyelinated fibres to noxius stimuli. J Neurophysiol. 1969;32:1025-1043.

  4. Campero M. Ectopic impulse generation and autoexcitation in single myelinated afferent fibers in patients with peripheral neuropathy and positive sensory symptoms. Muscle and Nerve. 1998;21:1661-1667.

  5. Catafau S, Bosque Q. Antiepilépticos en el manejo del dolor neuropático. Editorial Médica Panamericana. ISBN 9788479038410, 2003.

  6. Coghill RC. The roles of spatial recruitment and discharge frequency in spinal cord coding of pain: a combined electrophysiological and imaging investigation. Pain. 1993;53:295-309.

  7. De la OM, Godinez B, Guevara U, Cortés AR, López F. Efecto antihiperalgésico de una combinación de morfina y gabapentina en dolor neuropático inducido por constricción crónica en rata. Artemisa. 2007;75:363-369.

  8. DeLeo JA, Coombs DW, Willenbring S, Colburn RW, Fromm C, Wagner R, et al. Characterization of a neuropathic pain model: sciatic cryoneurolysis in the rat. Pain. 1994;56:9-16.

  9. Dubner R. Neuronal plasticity and pain following peripheral tissue inflammation of nerve injury. Amsterdam. 1991;263-276.

  10. Franek M, Vaculin S. Role of GABAB receptor agonist Baclofen in acute pain modulation during the early postnatal period. Pharmacology. 2009;84:104-110.

  11. González-Darder JM. Modelos animales de dolor y aspectos éticos de la experimentación animal. Rev Soc Esp Dolor. 2000;7:313-318.

  12. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental espinal nerve ligation in the rat. Pain. 1992;50:355-363.

  13. Koerster J. Principles of neural science. 3a ed. Estados Unidos, 1991.

  14. LaMotte RH. Neurogenic hyperalgesia:psychophysical studies of underlying mechanisms. J. Neurophysiol. 1991;66:190-211.

  15. Landry M, Nagy F. GABA(B) receptors and sensitization to pain. J Soc Biol. 2009;203:87-97.

  16. Lindblom U, Verillo RT. Sensory functions in chronic neuralgia. J Neurol Neurosurg Psychiatry. 1979;42:422-435.

  17. Lisney SJ, Devor M. Afterdischarge and interactions among fibres in damaged peripheral nerve in the rat. Brain Res. 1987;415:122-136.

  18. López I, Troncoso M, Avaria MA, Clunes A, Hernández M. Efectividad de baclofeno en el tratamiento de espasticidad de origen cerebral. Rev Chil Pediatr. 1996;67:206-211.

  19. McCleane G. Pharmacological management of neuropathic pain. CNS Drugs. 2003;17:1031-1043.

  20. Nyström B, Hagbarth KE. Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett. 1981;27:211-216.

  21. Nordin M, Nyström B, Wallin U, Hagbarth KE. Ectopic sensory discharges and paresthesias in patients with disorders of peripheral nerves, dorsal roots and dorsal columns. Pain. 1984;20:231-245.

  22. Ochoa J, Torebjörk E. Sensation evoked by intraneural microstimulation of C nocioceptor fibres in human skin nerves. J Physiol. 1989; 415:583-599.

  23. Ochoa J. Pain in local nerve lesions. New York: Oxford University Press. 1982.

  24. Rasminsky M. Ephaptic transmission between single nerve fibres in the spinal nerve roots of dystrophic mice. J Physiol. 1980;305:151-169.

  25. Ribera M. Definición, terminología y clasificación del dolor neuropático. España: Sociedad Española del Dolor. Presentado en VIII Reunión de la sociedad del Dolor (Ferrol 2006), 2006.

  26. Roberts MHT. Denervation suepersensitiviy in the central nervous system: possible relation to central pain syndromes. Raven Press, New York; 1991. pp. 219-231.

  27. Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science. 1991;251:1608-1610.

  28. Scadding JW. Developmnet of ongoing activity, mechanosensitivity and adrenalin sensitivity in severed peripheral nerve axons. Exp Neurol. 1981;73:345-364.

  29. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neutopathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205-218.

  30. Serra J, Peres J. Sensibilidad y su patología. En: Codina Puiggrós A. ed. Tratado de Neurología. Madrid Libro del Año, Arán Grupo. 1994; pp. 7-16.

  31. Simone DA. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol. 1991;66:228-246.

  32. Tal M, Bennett GJ. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain. 1994;57:375-382.

  33. Tinel J. Le signe du “fourmillement” dans les lesions des nerfs peripheriques. Press Med. 1915;47:388-389.

  34. Torebjörk HE. Afferenet C units responding to mechanical, termal and chemical stimuli in human non-glabrous skin. Acta Physiol Scand. 1974;92:374-390.

  35. Torebjörk HE. Central changes in the processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol. 1992;448:765-780.

  36. Hagbarth KE. Microelectrode recordings from human peripheral nerves (microneurography). Muscle & Nerve. 2002;25:S28-S35.

  37. Wall P, Melzac R. Textbook of pain. Edinburgh: Churchill Livingstone, 1994.

  38. Wallin G. Preliminary observations on the pathophysiology oh hyperalgesia in the causalgic pain syndrome. Oxford: Pergamon Press. 1976;489-502.

  39. Woolf CJ. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 1992;355:75-78.

  40. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87-107.

  41. Liu ZL, Ma H, Xu RX, Dai YW, Zhang HT, Yao XQ, et al. Potassium channels underlie postsynaptic but not presynaptic GABAB receptor-mediated inhibition on ventrolateral periaqueductal gray neurons. Brain Res Bull. 2012;88:529-533.

  42. Zimmermann M. Central nervous mechanisms modulating pain-related information: do they become deficient after lesions of the peripheral or central nervous system? Pain and central nervous. Cell. 1991;60:585-595.

  43. NORMA Oficial Mexicana NOM-012-SSA3-2012. Disponible en: http://www.dof.gob.mx, SEGOB, Mexico City. México.




2020     |     www.medigraphic.com